Related Experiment Video

Updated: Jun 14, 2026

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency

Bernice Lo1, Jill M Fritz2, Helen C Su3

  • 1Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar; Molecular Development of the Immune System Section, Laboratory of Immunology, Clinical Genomics Program.

Blood
|July 16, 2016
PubMed

Insights

Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) deficiency causes immune disorders. CTLA-4 blockade in cancer therapy mimics this deficiency, highlighting CTLA-4

Area of Science:

  • Immunology
  • Genetics
  • Oncology

Background:

  • Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a key inhibitory checkpoint molecule regulating immune activation.
  • Genetic defects leading to CTLA-4 deficiency result in immune dysregulation and lymphoproliferative diseases.
  • CTLA-4 blockade is a significant strategy in cancer immunotherapy.

Purpose of the Study:

  • To review the two genetic diseases associated with CTLA-4 deficiency.
  • To discuss the implications of CTLA-4 blockade in cancer immunotherapy.
  • To emphasize the critical role of CTLA-4 in immune checkpoint regulation.

Main Methods:

  • Review of recent scientific literature on CTLA-4 deficiency and blockade therapy.
  • Analysis of patient data from genetic studies.
  • Synthesis of findings related to immune dysregulation and cancer treatment.

Main Results:

  • Two distinct genetic diseases directly or indirectly cause CTLA-4 deficiency.
  • Immune dysregulation and lymphoproliferative disorders are consequences of CTLA-4 deficiency.
  • Treatment-induced CTLA-4 deficiency through blockade therapy leads to specific side effects.

Conclusions:

  • CTLA-4 plays a crucial role in maintaining immune homeostasis.
  • Understanding CTLA-4 deficiency is vital for both genetic disease management and cancer immunotherapy.
  • Further research into CTLA-4 function can optimize immune checkpoint regulation strategies.

More Related Videos

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...